# Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy

> **NCT05663580** · — · RECRUITING · sponsor: **Castagna Antonella** · enrollment: 1500 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL

## Key facts

- **NCT ID:** NCT05663580
- **Lead sponsor:** Castagna Antonella
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-17
- **Primary completion:** 2024-07-17
- **Final completion:** 2027-07-17
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05663580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05663580, "Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05663580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*